Ataraxis Ai

Ataraxis Ai company information, Employees & Contact Information

Explore related pages

Related company profiles:

Ataraxis is an AI precision medicine company transforming cancer diagnostics and patient outcomes through the power of AI. We are addressing previously unsolvable problems in cancer prognosis and treatment selection through cutting-edge foundation models and multi-modal data. Our first clinically validated offering, Ataraxis Breast, is the world’s first AI-native prognostic/predictive test for breast cancer and provides greater accuracy than standard of care genomic assays. To learn more, visit ataraxis.ai.

Company Details

Employees
29
Founded
-
Address
169 Madison Ave, New York,ny 10016,united States
Industry
Biotechnology
HQ
New York, NY
Looking for a particular Ataraxis Ai employee's phone or email?

Ataraxis Ai Questions

News

Exclusive: Not all cancer patients need chemo — Ataraxis AI raised $20M to personalize treatment - TechCrunch

Exclusive: Not all cancer patients need chemo — Ataraxis AI raised $20M to personalize treatment TechCrunch

Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A - Business Wire

Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A Business Wire

Spanish oncology research group MEDSIR infuses AI into breast cancer trials - Fierce Biotech

Spanish oncology research group MEDSIR infuses AI into breast cancer trials Fierce Biotech

Backed by Peter Thiel, Ataraxis AI secures $20.4M to expand its cancer prediction toolkit - FirstWord Pharma

Backed by Peter Thiel, Ataraxis AI secures $20.4M to expand its cancer prediction toolkit FirstWord Pharma

Ataraxis AI Raises $20.4M Series A - citybiz

Ataraxis AI Raises $20.4M Series A citybiz

NYU Langone offshoot raises $20M in growing field of AI cancer diagnostics - Crain's New York Business

NYU Langone offshoot raises $20M in growing field of AI cancer diagnostics Crain's New York Business

Precision Cancer Diagnostic Firm Ataraxis AI Launches - Inside Precision Medicine

Precision Cancer Diagnostic Firm Ataraxis AI Launches Inside Precision Medicine

The AlleyWatch Startup Daily Funding Report: 3/6/2025 - AlleyWatch

The AlleyWatch Startup Daily Funding Report: 3/6/2025 AlleyWatch

Ataraxis AI Launches to Transform Precision Medicine Beginning with World’s First AI-native Cancer Diagnostic - AI Insider

Ataraxis AI Launches to Transform Precision Medicine Beginning with World’s First AI-native Cancer Diagnostic AI Insider

AI model predicts progression of breast cancer better than standard hospital tests, study claims - Medical Xpress

AI model predicts progression of breast cancer better than standard hospital tests, study claims Medical Xpress

This AI Model Could Keep Thousands Of Cancer Patients From Getting Unnecessary Treatments - Forbes

This AI Model Could Keep Thousands Of Cancer Patients From Getting Unnecessary Treatments Forbes

#NYCtech Week in Review: 1/5/25 – 1/11/25 - AlleyWatch

#NYCtech Week in Review: 1/5/25 – 1/11/25 AlleyWatch

Ataraxis AI Raises $4M in Seed Funding - FinSMEs

Ataraxis AI Raises $4M in Seed Funding FinSMEs

U.S. Personalized Medicine Market Size to Surpass USD 705.88 Billion by 2034 - BioSpace

U.S. Personalized Medicine Market Size to Surpass USD 705.88 Billion by 2034 BioSpace

Top Ataraxis Ai Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant